Ablation of p57+ Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors

Cancer Research - Tập 83 Số 9 - Trang 1393-1409 - 2023
Takeru Oka1, Tsunaki Higa1, Osamu Sugahara1, Daisuke Koga1, Shogo Nakayama1, Keiichi I. Nakayama1
11Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.

Tóm tắt

Abstract Quiescent cancer stem cells (CSC) are resistant to conventional anticancer treatments and have been shown to contribute to disease relapse after therapy in some cancer types. The identification and characterization of quiescent CSCs could facilitate the development of strategies to target this cell population and block recurrence. Here, we established a syngeneic orthotopic transplantation model in mice based on intestinal cancer organoids to profile quiescent CSCs. Single-cell transcriptomic analysis of the primary tumors formed in vivo revealed that conventional Lgr5high intestinal CSCs comprise both actively and slowly cycling subpopulations, the latter of which specifically expresses the cyclin-dependent kinase inhibitor p57. Tumorigenicity assays and lineage tracing experiments showed that the quiescent p57+ CSCs contribute in only a limited manner to steady-state tumor growth but they are chemotherapy resistant and drive posttherapeutic cancer recurrence. Ablation of p57+ CSCs suppressed intestinal tumor regrowth after chemotherapy. Together, these results shed light on the heterogeneity of intestinal CSCs and reveal p57+ CSCs as a promising therapeutic target for malignant intestinal cancer. Significance: A quiescent p57+ subpopulation of intestinal CSCs is resistant to chemotherapy and can be targeted to effectively suppress the recurrence of intestinal cancer.

Từ khóa


Tài liệu tham khảo

Clevers, 2011, The cancer stem cell: premises, promises and challenges, Nat Med, 17, 313, 10.1038/nm.2304

Batlle, 2017, Cancer stem cells revisited, Nat Med, 23, 1124, 10.1038/nm.4409

Takeishi, 2013, Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence, Cancer Cell, 23, 347, 10.1016/j.ccr.2013.01.026

Oshimori, 2015, TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma, Cell, 160, 963, 10.1016/j.cell.2015.01.043

Kurtova, 2015, Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance, Nature, 517, 209, 10.1038/nature14034

Kumar, 2021, Dll1(+) quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway, Nat Commun, 12, 432, 10.1038/s41467-020-20664-5

Chen, 2012, A restricted cell population propagates glioblastoma growth after chemotherapy, Nature, 488, 522, 10.1038/nature11287

Takeishi, 2016, To wake up cancer stem cells, or to let them sleep, that is the question, Cancer Sci, 107, 875, 10.1111/cas.12958

Baldominos, 2022, Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche, Cell, 185, 1694, 10.1016/j.cell.2022.03.033

de Sousa e Melo, 2017, A distinct role for Lgr5(+) stem cells in primary and metastatic colon cancer, Nature, 543, 676, 10.1038/nature21713

Shimokawa, 2017, Visualization and targeting of LGR5(+) human colon cancer stem cells, Nature, 545, 187, 10.1038/nature22081

Fumagalli, 2020, Plasticity of Lgr5-negative cancer cells drives metastasis in colorectal cancer, Cell Stem Cell, 26, 569, 10.1016/j.stem.2020.02.008

Barker, 2007, Identification of stem cells in small intestine and colon by marker gene Lgr5, Nature, 449, 1003, 10.1038/nature06196

Barker, 2009, Crypt stem cells as the cells-of-origin of intestinal cancer, Nature, 457, 608, 10.1038/nature07602

Schepers, 2012, Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas, Science, 337, 730, 10.1126/science.1224676

de Sousa, 2019, Cellular plasticity in intestinal homeostasis and disease, Cell Stem Cell, 24, 54, 10.1016/j.stem.2018.11.019

Drost, 2015, Sequential cancer mutations in cultured human intestinal stem cells, Nature, 521, 43, 10.1038/nature14415

Barriga, 2017, Mex3a marks a slowly dividing subpopulation of Lgr5+ intestinal stem cells, Cell Stem Cell, 20, 801, 10.1016/j.stem.2017.02.007

Maletzki, 2020, NSG mice as hosts for oncological precision medicine, Lab Invest, 100, 27, 10.1038/s41374-019-0298-6

Zitvogel, 2008, Immunological aspects of cancer chemotherapy, Nat Rev Immunol, 8, 59, 10.1038/nri2216

Bracci, 2014, Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer, Cell Death Differ, 21, 15, 10.1038/cdd.2013.67

Matsumoto, 2011, p57 is required for quiescence and maintenance of adult hematopoietic stem cells, Cell Stem Cell, 9, 262, 10.1016/j.stem.2011.06.014

Furutachi, 2015, Slowly dividing neural progenitors are an embryonic origin of adult neural stem cells, Nat Neurosci, 18, 657, 10.1038/nn.3989

Higa, 2022, Spatiotemporal reprogramming of differentiated cells underlies regeneration and neoplasia in the intestinal epithelium, Nat Commun, 13, 1500, 10.1038/s41467-022-29165-z

Lee, 2022, p57(Kip2) imposes the reserve stem cell state of gastric chief cells, Cell Stem Cell, 29, 826, 10.1016/j.stem.2022.04.001

Oshima, 1995, Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene, Proc Natl Acad Sci U S A, 92, 4482, 10.1073/pnas.92.10.4482

Sato, 2009, Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche, Nature, 459, 262, 10.1038/nature07935

Jia, 2018, A novel cell line generated using the CRISPR/Cas9 technology as universal quality control material for KRAS G12V mutation testing, J Clin Lab Anal, 32, e22391, 10.1002/jcla.22391

Cheung, 2020, Regenerative reprogramming of the intestinal stem cell state via Hippo signaling suppresses metastatic colorectal cancer, Cell Stem Cell, 27, 590, 10.1016/j.stem.2020.07.003

Iwano, 2018, Single-cell bioluminescence imaging of deep tissue in freely moving animals, Science, 359, 935, 10.1126/science.aaq1067

Enquist, 2014, Lymph node-independent liver metastasis in a model of metastatic colorectal cancer, Nat Commun, 5, 3530, 10.1038/ncomms4530

Hashimshony, 2016, CEL-Seq2: sensitive highly-multiplexed single-cell RNA-seq, Genome Biol, 17, 77, 10.1186/s13059-016-0938-8

Butler, 2018, Integrating single-cell transcriptomic data across different conditions, technologies, and species, Nat Biotechnol, 36, 411, 10.1038/nbt.4096

Ma, 2020, Integrative differential expression and gene set enrichment analysis using summary statistics for scRNA-seq studies, Nat Commun, 11, 1585, 10.1038/s41467-020-15298-6

Gulati, 2020, Single-cell transcriptional diversity is a hallmark of developmental potential, Science, 367, 405, 10.1126/science.aax0249

Ke, 2013, SeeDB: a simple and morphology-preserving optical clearing agent for neuronal circuit reconstruction, Nat Neurosci, 16, 1154, 10.1038/nn.3447

Sargent, 2009, Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials, J Clin Oncol, 27, 872, 10.1200/JCO.2008.19.5362

Vodenkova, 2020, 5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future, Pharmacol Ther, 206, 107447, 10.1016/j.pharmthera.2019.107447

Tauriello, 2018, TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis, Nature, 554, 538, 10.1038/nature25492

Marusyk, 2020, Intratumor heterogeneity: the rosetta stone of therapy resistance, Cancer Cell, 37, 471, 10.1016/j.ccell.2020.03.007

Fumagalli, 2017, Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids, Proc Natl Acad Sci U S A, 114, E2357, 10.1073/pnas.1701219114

Clevers, 2014, Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control, Science, 346, 1248012, 10.1126/science.1248012

Flanagan, 2021, NOTUM from Apc-mutant cells biases clonal competition to initiate cancer, Nature, 594, 430, 10.1038/s41586-021-03525-z

van Neerven, 2021, Apc-mutant cells act as supercompetitors in intestinal tumour initiation, Nature, 594, 436, 10.1038/s41586-021-03558-4

Wharton, 2001, Vertebrate proteins related to drosophila naked cuticle bind dishevelled and antagonize Wnt signaling, Dev Biol, 234, 93, 10.1006/dbio.2001.0238

Nazio, 2019, Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications, Cell Death Differ, 26, 690, 10.1038/s41418-019-0292-y

Signer, 2014, Haematopoietic stem cells require a highly regulated protein synthesis rate, Nature, 509, 49, 10.1038/nature13035

O'Brien, 2007, A human colon cancer cell capable of initiating tumour growth in immunodeficient mice, Nature, 445, 106, 10.1038/nature05372

Ricci-Vitiani, 2007, Identification and expansion of human colon-cancer-initiating cells, Nature, 445, 111, 10.1038/nature05384

Chang, 2019, Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin, FASEB J, 33, 114, 10.1096/fj.201800019RR

Haak, 2021, Debris-stimulated tumor growth: a Pandora's box?, Cancer Metastasis Rev, 40, 791, 10.1007/s10555-021-09998-8

Shiokawa, 2020, Slow-cycling cancer stem cells regulate progression and chemoresistance in colon cancer, Cancer Res, 80, 4451, 10.1158/0008-5472.CAN-20-0378

Ohta, 2022, Cell-matrix interface regulates dormancy in human colon cancer stem cells, Nature, 608, 784, 10.1038/s41586-022-05043-y